Financials
Value Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 60.89 K71.43 K175.88 K134.5 K 442.7 K Research & development ———— — Operating income -458.51 K-71.43 K-175.88 K-134.5 K -840.32 K Non-Operating Income, Total ——1.25 M1.26 M — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses ——1.25 M1.26 M — Unusual income/expense ———— — Pretax income -458.51 K-71.43 K1.07 M1.13 M 1.67 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -60.89 K266.19 K1.07 M1.13 M 2.41 M Discontinued operations ———— — Net income -60.89 K266.19 K1.07 M1.13 M 2.41 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -60.89 K266.19 K1.07 M1.13 M 2.41 M Basic earnings per share (Basic EPS) -0.01—0.20.24 — Diluted earnings per share (Diluted EPS) -0.010.040.20.24 0.47 Average basic shares outstanding 4.17 M6.62 M19.64 M19.64 M — Diluted shares outstanding 4.17 M6.62 M39.28 M39.28 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —